Feedback / Questions
AGX101 - Angiex
https://www.globenewswire.com/news-release/2023/11/02/2772778/0/en/Angiex-Announces-FDA-Clearance-of-IND-Application-for-AGX101-a-novel-First-in-Class-TM4SF1-Directed-Antibody-Drug-Conjugate-for-the-Treatment-of-Solid-Cancers.html
Nov 2, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious